About usThe Cell Biology department combines a leading role in research and teaching in molecular life sciences. They are interested in research related to cancer metastasis, cellular metabolism, cellular immunity and neurodegenerative disease.
STORMy discoveries by our cell biologists
Daniele Tauriello co-founded a new research initiative with the aim of advancing clinical translation for colorectal cancer.This new research group is a cross-disciplinary research collaboration of four Radboudumc groups, read more
Daniele Tauriello co-founded a new research initiative with the aim of advancing clinical translation for colorectal cancer.
This research group is part of four research departments:
- Cell Biology
- Medical oncology
It is our mission to improve the outcome of patients with CRC, to enlarge our understanding of CRC biology, and to educate researchers and clinicians at all levels of their careers. Our innovative collaboration of cancer biologists, pharmacologists, pathologists, and medical oncologists enables purposeful research that goes from molecules to cells and to the patient, and vice versa.
We focus our translational research on new treatment paradigms: novel targets, improved treatment regimes, and synergistic combination strategies. Our specific expertise includes targeted therapy, regimen optimization, drug development, pharmacology, pathology, biomarkers, microbiota, and the tumour immune microenvironment.
By combining our strengths, we aim to break new ground in overcoming patient-specific drug resistance and immune evasion mechanisms; to develop and test individual therapy combinations in patient-derived 3D models; and to translate our findings into the clinic. We believe this cross-disciplinary approach can significantly improve CRC treatment efficacy while reducing adverse effects.
More information, please visit our website
Breakfast@Cell Biology once every 6 weeks!
The department of Cell Biology invites colleagues to give a seminar about their current research issues. The topics range from molecule to men to population with the aim of bridging fundamental cell biological research with clinical questions.
Breakfast in June:
28 June 2021
Guest speaker: Hannie Kremer and the title of her presentation will be:
"The molecular genetics of hearing loss or ‘quer durch den Garten’ of cell biology".
Time: 9.15-10.15 incl. discussion.
More variants TLR7 gene found in young healthy men with severe Covid-19Screening and accelerated vaccination for TLR7 immunodeficiency3 August 2021
Sonlicromanol seems promising for certain cancersKhondrion announces publication in PLOS ONE of new research13 July 2021
EM center on NPO25 May 2021
Tumor cells and a calpain inhibitorAt the recent annual New Year's meeting for employees, we took a look at Peter Friedl's research.
Radboud Institute for Molecular Life Sciences
Geert Grooteplein 28
6525 GA Nijmegen